Log In
Print this Print this

PNAClamp EGFR mutation detection kit

  Manage Alerts
Collapse Summary General Information
Company Panagene Inc.
DescriptionTest to detect mutations in EGFR DNA sequences using real time PCR technology with PNA clamps
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsTest drug resistance of patients with lung cancer, EGFR 29 mutation detection (exon19-21)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today